首页/数据集/Benefit-harm analysis for informed decision making about participating in col...

Benefit-harm analysis for informed decision making about participating in col...

B2FIND2026-04-29 收录

大肠癌筛查

医疗决策辅助

数据链接：

https://b2find.eudat.eu/dataset/daab958c-ca16-52cf-aa4f-394bbabe2b0c 数据链接链接失效反馈

官方服务：

资源简介：

The aim of this research project was to help screening invitees make an informed decision about participating in colorectal cancer screening, by developing an online decision...

应用场景：

大肠癌筛查

风险评估

Fecal Immunochemical Testing (FIT) is a central tool in colorectal cancer (CRC) screening. To improve the selection of individuals for colonoscopy, risk models combining FIT with additional CRC risk f

Figshare2023-11-14 更新140

Epidemiological Study of Colorectal Cancer in WuHan

大肠癌筛查

环境流行病学

The incidence risk of colorectal cancer （CRC） is increasing at 4.2% year by year in China. Most effective way to reduce the death rate of CRC patients is to diagnose in quite an early stage. QiaoKou D

NIAID Data Ecosystem90

A Telephone Intervention to Improve Participation in a Screening Program.

大肠癌筛查

电话干预

Objective: To assess the effectiveness of a brief telephone intervention added to an post invitation letter in the participation rate to a colorectal cancer screening program. Methods: Randomized cont

NIAID Data Ecosystem50

Screening Tests in Detecting Colorectal Cancer

大肠癌筛查

诊断方法比较

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for colorectal cancer. PURPOSE: Randomized screening trial to compare the effectiveness of fecal

NIAID Data Ecosystem90

Expected detection rate and associated NNS to detect 1 case of any advanced neoplasm and cancer at screening colonoscopy at age 55 after annual FIT testing from age 50 to age 54, compared to no preceding FIT testing and to strategies with longer intervals between FITs.

大肠癌筛查

FIT粪便免疫化学检测

NIAID Data Ecosystem80